Sanofi (NYS: SNY) reported earnings on April 27. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q1), Sanofi met expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue improved slightly and GAAP earnings per share expanded significantly.
Gross margins contracted, operating margins improved, and net margins improved.
Sanofi logged revenue of $11.35 billion. The 12 analysts polled by S&P Capital IQ foresaw revenue of $11.48 billion on the same basis. GAAP reported sales were 2.5% higher than the prior-year quarter's $11.62 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $2.47. The eight earnings estimates compiled by S&P Capital IQ averaged $2.23 per share. GAAP EPS of $1.84 for Q1 were 39% higher than the prior-year quarter's $1.32 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 70.6%, 50 basis points worse than the prior-year quarter. Operating margin was 26.0%, 20 basis points better than the prior-year quarter. Net margin was 20.4%, 550 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $11.52 billion. On the bottom line, the average EPS estimate is $1.90.
Next year's average estimate for revenue is $45.86 billion. The average EPS estimate is $7.71.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Sanofi is outperform, with an average price target of $81.64.
Can your portfolio provide you with enough income to last through retirement? You'll need more than Sanofi. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.
Add Sanofi to My Watchlist.
At the time thisarticle was published Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.